http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20170899-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c5e77c181522ee1fd44df1ae5ac2196
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
filingDate 2015-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60913a87f877ab53274e31cf022a7f7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b4b7a5b09d1e7940bd850759b14d6ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_032f666ac5473f2b7d87a7d985d653bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_375988c2343fc346e55c53d81f0dd00a
publicationDate 2017-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20170899-A1
titleOfInvention 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINES AS GPR MODULATORS 139
abstract It refers to 4-oxo-3,4-dihydro-1,2,3-benzotriazines compounds of formula (I) where m and n are 0, 1 or 2; R1 is cyano, halo, hydroxy, among others; R4 is cyano, halo, fluoromethoxy, among others; R5 is H, trifluoromethyl, among others. A compound selected is 2- (5-methoxy-4-oxobenzo [d] [1,2,3] triazin-3 (4H) -yl) -N- (1-p-tolylethyl) acetamide; among others. It also refers to a composition and a combination. Said compounds are modulators of the orphan G protein coupled receptor (GPR 139), being useful in the treatment of schizophrenia, autism spectrum disorder, among others.
priorityDate 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414860566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135408793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655

Total number of triples: 34.